Related Experiment Video

Updated: Mar 19, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

ERBB2 oncogenicity: ERBIN helps to perform the job

Lin Mei1, Jean-Paul Borg2

  • 1Department of Neuroscience and Regenerative Medicine and Department of Neurology; Medical College of Georgia; Georgia Regents University ; Augusta, GA, USA.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

ERBB2 (v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2) is a key protein in breast cancer. New research shows ERBB2IP (ERBB2 interacting protein), also known as ERBIN, influences ERBB2 stability, offering a potential new therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • ERBB2 (v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2) is an oncogenic tyrosine kinase receptor frequently overexpressed in breast cancer.
  • Current therapies targeting ERBB2, including antibodies and inhibitors, often face therapeutic failures.

Purpose of the Study:

  • To review recent data on the role of ERBB2IP (ERBB2 interacting protein), also known as ERBIN, in regulating ERBB2.
  • To explore ERBB2IP as a potential future therapeutic target for ERBB2-overexpressing cancers.

Main Methods:

  • Literature review of recent studies on ERBB2 and ERBB2IP.
  • Analysis of data concerning the interaction between ERBB2 and ERBB2IP.
  • Discussion of the implications of ERBB2IP's role in ERBB2 stability.

Main Results:

  • ERBB2IP (ERBIN) has been identified as a scaffold protein that regulates the stability of the ERBB2 receptor.
  • The interaction between ERBB2IP and ERBB2 is crucial for controlling ERBB2 levels and signaling.

Conclusions:

  • ERBB2IP (ERBIN) plays a significant role in managing ERBB2 stability.
  • Targeting ERBB2IP represents a promising novel therapeutic strategy for breast cancer and other ERBB2-driven malignancies.
Keywords:
ERBB2ErbinHER2PDZ domainbreast cancerprotein stability

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.4K
A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

10.3K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K